[{"notes_id":"1_1365","category":"10","subcategory":"1","title":"Nephrotoxicity due to contrast media","body":"Contrast media nephrotoxicity may be defined as a 25% increase in creatinine occurring within 3 days of the intravascular administration of contrast media. <span class=\"concept\" data-cid=\"9796\">Contrast-induced nephropathy occurs 2 -5 days after administration.<\/span><br \/><br \/>Risk factors include<br \/><ul><li>known renal impairment (especially diabetic nephropathy)<\/li><li>age > 70 years<\/li><li>dehydration<\/li><li>cardiac failure<\/li><li>the use of nephrotoxic drugs such as NSAIDs<\/li><\/ul><br \/>Examples of procedures that may cause contrast-induced nephropathy includes:<br \/><ul><li>CT with contrast<\/li><li><span class=\"concept\" data-cid=\"11283\">coronary angiography\/percutaneous coronary intervention (PCI)<\/span><ul><li>around 5% of patients who've undergone PCI develop a transient rise in the plasma creatinine concentration of more than 88 \u00b5mol\/L<\/li><\/ul><\/li><\/ul><br \/>Prevention<br \/><ul><li>the evidence base currently supports the use of <span class=\"concept\" data-cid=\"9609\">intravenous 0.9% sodium chloride<\/span> at a rate of 1 mL\/kg\/hour for 12 hours pre- and post- procedure. There is also evidence to support the use of isotonic sodium bicarbonate<\/li><li>N-acetylcysteine has been given in the past but recent evidence suggests it is not effective*<\/li><\/ul><br \/>Patients who are high-risk for contrast-induced nephropathy should have <span class=\"concept\" data-cid=\"11274\">metformin<\/span> withheld for a minimum of 48 hours and until the renal function has been shown to be normal.  This is due to the risk of lactic acidosis.<br \/><br \/>* Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med. 2018;378(7):603","notes_hash":"0f0388be6d685c9b4aed57a5785a42f6","knowledge_graph_node_id_link":0,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1994\" data-linkid=\"1994\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1994\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">5<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1994\" data-linkid=\"1994\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1994\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">2<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng148\/evidence\/a-preventing-contrastinduced-acute-kidney-injury-pdf-7019265566\">2019 Evidence review for preventing contrastinduced acute kidney injury<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":{"9609":{"concept_text":"Prevention of contrast-induced nephropathy: volume expansion with 0.9% saline","concept_percentile":"54"}},"category_name":"Renal \/ Urology","subcategory_name":"Renal","comment_count":4},"",[]]